# A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia

> **NCT06285825** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 32 (estimated)

## Conditions studied

- Cytopenia

## Interventions

- **DRUG:** Emapalumab

## Key facts

- **NCT ID:** NCT06285825
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-05
- **Primary completion:** 2026-08-22
- **Final completion:** 2028-08-22
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285825, "A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT06285825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*